Raymond James Financial Services Advisors »

Lexaria Bioscience shares owned by Raymond James Financial Services Advisors

Quarter-by-quarter ownership of Lexaria Bioscience (LEXX) shares owned by Raymond James Financial Services Advisors from 13F filings

Historical chart of Raymond James Financial Services Advisors investment in Lexaria Bioscience

Tip: Access up to 7 years of quarterly data

All positions including Lexaria Bioscience held by Raymond James Financial Services Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexaria Bioscience by Raymond James Financial Services Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $137k 45k 3.05
2024-06-30 $136k 49k 2.78
2024-03-31 $144k 40k 3.63

More positions owned by Raymond James Financial Services Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Vanguard Index Fds Value Etf (VTV)
Broadcom (AVGO)
Vanguard Index Fds Total Stk Mkt (VTI)
Home Depot (HD)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Wal-Mart Stores (WMT)

View all positions for Raymond James Financial Services Advisors

Top funds holding Lexaria Bioscience

Armistice Capital
Invenomic Capital Management
Geode Capital Management
Vanguard Group
GenTrust
Raymond James Financial Services Advisors
State Street Corporation
BlackRock
Welch Group
Morgan Stanley
Renaissance Technologies
Wealth Enhancement Advisory Services
XTX Topco
Royal Bank of Canada
Oakworth Capital

View all funds holding Lexaria Bioscience